Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

The link between glutamate and migraine.

Nabih M Ramadan¹

¹Department of Neurology, Finch University of Health Sciences/The Chicago Medical School, Chicago, Illinois 60064-3095, USA. ramadan@finchcms.edu

|July 15, 2003

Summary

Glutamate plays a key role in migraine pain pathways. Targeting glutamate receptors shows promise for developing new migraine therapies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Ocular and Cervical Vestibular Evoked Myogenic Potentials in Patients With Vestibular Migraine.

Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology·2018

Same author

Glutamate and migraine: from Ikeda to the 21st century.

Cephalalgia : an international journal of headache·2013

Same author

Commentary on headache currents articles by Alhazzani and Goddeau.

Headache·2013

Same author

Reduced adverse event profile of orally inhaled DHE (MAP0004) vs IV DHE: potential mechanism.

Headache·2009

Same author

Safety and pharmacokinetics of dihydroergotamine mesylate administered via a Novel (Tempo) inhaler.

Headache·2008

Same author

Current trends in migraine prophylaxis.

Headache·2007

Area of Science:

Neuroscience
Pain Research
Pharmacology

Background:

Migraine involves pain signaling centers like the trigeminal ganglion and thalamus.
Glutamate, a neurotransmitter, is present in these pain-relay centers and activates key migraine pathways.
Glutamate is linked to cortical spreading depression, trigeminovascular activation, and central sensitization in migraine.

Purpose of the Study:

To investigate the role of the glutamatergic system in migraine pathophysiology.
To highlight the therapeutic potential of targeting glutamate receptors for migraine treatment.

Main Methods:

Review of preclinical models of migraine.
Analysis of clinical data on glutamate receptor-subtype antagonists.

Main Results:

Glutamate-positive neurons are found in migraine pain-relay centers.
Glutamate receptor-subtype antagonists demonstrate efficacy in preclinical migraine models.
These antagonists show effectiveness in clinical migraine treatment.

Conclusions:

A significant link exists between the glutamatergic system and migraine.
Further characterization of this link is crucial for understanding migraine mechanisms.
Targeting the glutamatergic system offers a promising therapeutic strategy for effective migraine management.

Related Experiment Videos